Search

everythinglearnresearchcommunity

for

Search:↓

Exprecell™ is as effective as traditional methods but produces more f-PRF and is simpler to use.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Tofacitinib might be used to treat hair loss.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Ixekizumab has known and some unexpected side effects.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Gene therapy in mice increased lifespan and improved health without causing cancer.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

The combination treatment showed a higher response rate but no significant survival benefits.

All HPV vaccine studies should be registered and published to reduce reporting bias.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Compound 6 is a promising candidate for better wound healing.

The Enriched-GF method efficiently produces high-yield growth factors for tissue repair.

A new combination of tadalafil and finasteride improves drug performance and stability.

Platelet-derived exosomes offer better regenerative therapy but face challenges in isolation and regulation.

Combining PEMF with PBST is more effective for hair regrowth than PBST alone.

Stem cell therapies are advancing quickly with new technologies and need supportive regulations for clinical use.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Improved finasteride formula allows slow, sustained release and better absorption for patients.